Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective
about
Comparison of Diagnostic Sensitivity and Quantitative Indices Between (68)Ga-DOTATOC PET/CT and (111)In-Pentetreotide SPECT/CT in Neuroendocrine Tumors: a Preliminary Report.68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors(68) Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting.Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients.A 3D Monte Carlo Method for Estimation of Patient-specific Internal Organs Absorbed Dose for (99m)Tc-hynic-Tyr(3)-octreotide Imaging.Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in childrenImaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.Impact of Ga-DOTA-Peptide PET/CT on the Management of Gastrointestinal Neuroendocrine Tumour (GI-NET): Malaysian National Referral Centre ExperienceIncidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases
P2860
Q36241229-1E31D18D-9272-4DD6-BE48-EAA7841A8741Q36275598-F17806F9-E010-4F84-80F7-21DF96E99C37Q37214513-251BE019-6BE7-4947-8BFE-4E7AAEB23BFBQ37717372-1540733B-191C-4842-BE6C-21B10CEDD7E6Q38676211-9AC47DAC-55FC-4B4E-A5F3-9AE84232FB96Q39016753-F9E70B2F-EBB3-49D1-B371-9933CA0F3779Q39284731-062AE061-D272-49D0-9B45-0CA9584CAA72Q39475351-39D81BEE-D461-4D07-AAB3-1132390230E9Q39550058-A5055CAF-1920-42ED-BE98-76E37C58A6FBQ42653448-EBADCB11-5D63-45C7-AC93-AE9CC6319312Q43066318-19E7025B-15BC-4C51-89AA-FC00C13EF274Q50511434-C1463784-ED6E-4DB7-8E25-6896359664F7Q56561029-B1BCBA35-4A11-4394-B91A-B1D04AE2FE45Q57640624-8DFCDD27-9E85-4002-B3CB-A5FB860EA22B
P2860
Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of 68Ga-DOTATATE PET/CT ...... erring physician's perspective
@en
Impact of 68Ga-DOTATATE PET/CT ...... rring physician's perspective.
@nl
type
label
Impact of 68Ga-DOTATATE PET/CT ...... erring physician's perspective
@en
Impact of 68Ga-DOTATATE PET/CT ...... rring physician's perspective.
@nl
prefLabel
Impact of 68Ga-DOTATATE PET/CT ...... erring physician's perspective
@en
Impact of 68Ga-DOTATATE PET/CT ...... rring physician's perspective.
@nl
P2093
P2860
P1476
Impact of 68Ga-DOTATATE PET/CT ...... erring physician's perspective
@en
P2093
Antonio Gutierrez
Christiaan Schiepers
Edward M Wolin
Johannes Czernin
Ken Herrmann
Martin Barrio
Martin S Allen-Auerbach
Michael E Phelps
Pawan Gupta
Sherly Mosessian
P2860
P356
10.2967/JNUMED.114.148247
P407
P577
2014-12-11T00:00:00Z